# Pancytopenia

**Pancytopenia** is a condition in which the number of red blood cells, white blood cells, and platelets in the blood is lower than normal, so that anemia, leukopenia, and thrombocytopenia occur together<sup>[1](https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pancytopenia)</sup><sup> • </sup><sup>[2](https://bestpractice.bmj.com/topics/en-us/1024)</sup>. It is not a disease in itself but a laboratory finding produced by an underlying disease process affecting the bone marrow or the circulating cell lines<sup>[3](https://www.sciencedirect.com/science/article/pii/S0268960X17300838)</sup>.

| Key fact | Detail |
|---|---|
| Definition | A reduction of all three blood cell lines, red cells, white cells, and platelets, below the age-adjusted normal range<sup>[2](https://bestpractice.bmj.com/topics/en-us/1024)</sup> |
| Nature | A finding, not a disease; the cause must be identified in every case<sup>[3](https://www.sciencedirect.com/science/article/pii/S0268960X17300838)</sup><sup> • </sup><sup>[2](https://bestpractice.bmj.com/topics/en-us/1024)</sup> |
| Main mechanisms | Impaired production (bone marrow failure or marrow infiltration), peripheral destruction, and splenic sequestration<sup>[3](https://www.sciencedirect.com/science/article/pii/S0268960X17300838)</sup> |
| Common causes | Cancer and noncancerous bone marrow disorders; leukemia and myelodysplastic syndrome are common cancer diagnoses linked to it<sup>[4](https://my.clevelandclinic.org/health/diseases/25105-pancytopenia)</sup> |
| Other causes | Infection, poor nutrition, pregnancy, chemotherapy or radiation therapy, toxins, chemicals, medicines, autoimmune and genetic disorders<sup>[1](https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pancytopenia)</sup> |
| First detection | Automated complete blood count plus examination of the peripheral blood smear<sup>[2](https://bestpractice.bmj.com/topics/en-us/1024)</sup> |
| Aplastic anemia threshold | Suspected particularly in young patients with WBC < 1,500/µL and platelets < 50,000/µL<sup>[5](https://benhvienanhson.com/media/post_attachments/The_Merck_Manual_of_Diagnosis_and_Therapy_2011_-_19th_Edn........pdf)</sup> |

## Mechanisms

Reviews group the causes of pancytopenia into three broad categories<sup>[3](https://www.sciencedirect.com/science/article/pii/S0268960X17300838)</sup>:

- **Impaired production**, which covers both bone marrow failure disorders and marrow infiltration disorders.
- **Peripheral destruction** of the different cell lines, often immune-mediated.
- **Sequestration**, in which cells are trapped in the spleen.

When the marrow itself fails to produce cells, the result is aplastic anemia, the condition in which pancytopenia is caused by bone marrow failure<sup>[6](https://ncbi.nlm.nih.gov/books/NBK563146/)</sup>. Acquired aplastic anemia is characterized by T-cell mediated immune destruction of hematopoietic stem cells, producing a hypocellular marrow and pancytopenia<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC13499452/)</sup>. Production is also impaired when the marrow is infiltrated by malignancies such as lymphoma, leukemia, or multiple myeloma, by granulomatous disorders, or late in disease by metastatic tumors<sup>[6](https://ncbi.nlm.nih.gov/books/NBK563146/)</sup>.

Peripheral destruction is associated with autoimmune conditions such as systemic lupus erythematosus and rheumatoid arthritis, and with splenic sequestration seen in alcoholic liver cirrhosis, HIV, tuberculosis, and malaria<sup>[6](https://ncbi.nlm.nih.gov/books/NBK563146/)</sup>. Alcohol-related liver disease can cause blood cells to become trapped in the spleen<sup>[4](https://my.clevelandclinic.org/health/diseases/25105-pancytopenia)</sup>.

## Causes

The list of etiologies is wide: drugs, autoimmune conditions, malignancies, infections, hemophagocytosis, and inheritable conditions<sup>[3](https://www.sciencedirect.com/science/article/pii/S0268960X17300838)</sup>. The [National Cancer Institute](https://www.edgepedia.org/national-cancer-institute) adds infection, poor nutrition, pregnancy, cancer treatment such as chemotherapy or radiation therapy, and exposure to certain toxins, chemicals, or medicines<sup>[1](https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pancytopenia)</sup>.

**Which cause dominates varies by population.** In a Korean series of 1,580 cases (Bae and colleagues, 2015), the most common diagnosis was acute myeloid leukemia at 25.9%, followed by infections at 25.6%; in an Indian series of 414 cases from 2023, the most common diagnosis was megaloblastic anemia at 11.35%, followed by multiple myeloma at 8.2%<sup>[8](https://ijmscrr.in/index.php/ijmscrr/article/download/656/453/2214)</sup>. In a Pakistani tertiary care study of 106 patients, anemia-related complaints were the most common presentation at 91.5%, followed by infection at 64.2% and thrombocytopenia at 36.8%<sup>[9](https://pmc.ncbi.nlm.nih.gov/articles/PMC11554238/)</sup>.

Among adults whose pancytopenia was newly discovered, a review of 132 patients with no history of hematolymphoid neoplasia, no prior bone marrow study, and no recent cytotoxic chemotherapy found that 64% had clonal hematopoietic disorders; among the non-clonal cases, the most common specific diagnoses were aplastic anemia (5%), megaloblastic anemia (2%), and HIV-related changes (2%)<sup>[10](https://www.tandfonline.com/doi/full/10.3109/10428194.2013.821703)</sup>.

## Symptoms

Because all three blood cell lines are lacking, the resulting signs and symptoms reflect their lost functions: tiredness, weakness, lightheadedness, shortness of breath, a racing heart, fever, pallor, purple or red skin spots, rash, a tendency to bruise easily, and irregular bleeding.<sup>[1](https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pancytopenia)</sup> [Presentation](https://www.edgepedia.org/presentation) tends to be non-specific and can include fatigue, infection, and bleeding; patients may also be asymptomatic<sup>[3](https://www.sciencedirect.com/science/article/pii/S0268960X17300838)</sup><sup> • </sup><sup>[11](https://pubmed.ncbi.nlm.nih.gov/39159748/)</sup>.

## Diagnosis

The diagnosis of pancytopenia is made from an automated complete blood count and examination of the peripheral smear, but because the etiology varies significantly, a detailed diagnostic evaluation is required in every instance<sup>[2](https://bestpractice.bmj.com/topics/en-us/1024)</sup>.

**Initial workup** includes history (medications, infections, prior cytopenias), physical examination, and review of complete blood count trends<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC13499452/)</sup>. Based on clinical findings, further testing targets common etiologies: liver disease (liver function tests and clotting screen), viral infections including hepatitis B, hepatitis C, Epstein-Barr virus, cytomegalovirus, parvovirus B19, and HIV, parasite infections including malaria, schistosomiasis, and leishmaniasis, a hemolytic screen (haptoglobins and direct antiglobulin testing), an autoimmune screen for rheumatic disease, and nutritional deficiencies including haematinics, serum copper, and ceruloplasmin<sup>[11](https://pubmed.ncbi.nlm.nih.gov/39159748/)</sup>.

[Bone marrow examination](https://www.edgepedia.org/bone-marrow-examination) is central when the cause remains unclear. [Bone marrow](https://www.edgepedia.org/bone-marrow) aspiration provides cytological assessment of cell morphology and aids subtyping of leukemia and anemia, and trephine biopsy completes the evaluation; since many cases have a reversible etiology, marrow examination supports early and accurate diagnosis<sup>[12](https://doi.org/10.5005/jablm-11031-0007)</sup>.

**Distinguishing immune from non-immune marrow failure** has become a laboratory question. Until recently no tests distinguished immune-mediated bone marrow failure, which includes acquired aplastic anemia and a subset of low-risk myelodysplastic syndrome, from non-immune failure caused by genetic abnormalities in hematopoietic stem cells. Two principal abnormal populations, blood cells deficient in glycosylphosphatidylinositol-anchored proteins (GPI[-]) and leukocytes missing HLA class I alleles (HLA[-]), embody the immune mechanism behind bone marrow failure, and finding mature peripheral blood cells descended from mutated stem cells points to immune-mediated destruction.<sup>[13](https://pubmed.ncbi.nlm.nih.gov/36609840/)</sup>

## Relationship to aplastic anemia

[Aplastic anemia](https://www.edgepedia.org/aplastic-anemia) is the prototypical acquired bone marrow failure syndrome, defined by immune destruction of hematopoietic stem cells, a hypocellular marrow, and pancytopenia<sup>[7](https://pmc.ncbi.nlm.nih.gov/articles/PMC13499452/)</sup>. It is suspected particularly in young patients with pancytopenia, for example white blood cells below 1,500/µL and platelets below 50,000/µL<sup>[5](https://benhvienanhson.com/media/post_attachments/The_Merck_Manual_of_Diagnosis_and_Therapy_2011_-_19th_Edn........pdf)</sup>. Standard treatment options are hematopoietic stem cell transplantation or immunosuppressive therapy with antithymocyte globulin and ciclosporin<sup>[14](https://b-s-h.org.uk/media/18192/010420-versionkings-aa-guidance-covid19.pdf)</sup>. An almost uniformly fatal prognosis, mainly for young persons with sudden severe pancytopenia, has been reversed in the modern era with effective therapies for almost all patients<sup>[15](https://pmc.ncbi.nlm.nih.gov/articles/PMC6467577)</sup>.

## History

The combination of pancytopenia with aplastic bone marrow and physical anomalies was first described in 1927 by Fanconi, the syndrome now known as [Fanconi anemia](https://www.edgepedia.org/fanconi-anemia)<sup>[16](https://pmc.ncbi.nlm.nih.gov/articles/PMC4671105/)</sup>. Fanconi anemia is considered perhaps the first bone marrow failure syndrome to be characterized as a distinct entity<sup>[17](https://ashpublications.org/blood/article/124/18/2755/33349/Introduction-to-the-Review-Series-on-Bone-Marrow)</sup>.

## References

1. [Pancytopenia, NCI Dictionary of Cancer Terms, National Cancer Institute](https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pancytopenia)
2. [Evaluation of pancytopenia, BMJ Best Practice](https://bestpractice.bmj.com/topics/en-us/1024)
3. [Gnanaraj J, Parnes A, Francis CW, Go RS, Takemoto CM, Hashmi SK (2018). Approach to pancytopenia: Diagnostic algorithm for clinical hematologists. Blood Reviews 32(5):361-367.](https://www.sciencedirect.com/science/article/pii/S0268960X17300838)
4. [Pancytopenia: Symptoms, Causes & Treatment, Cleveland Clinic](https://my.clevelandclinic.org/health/diseases/25105-pancytopenia)
5. [The Merck Manual of Diagnosis & Therapy, 19th Edition, Chapter 105](https://benhvienanhson.com/media/post_attachments/The_Merck_Manual_of_Diagnosis_and_Therapy_2011_-_19th_Edn........pdf)
6. [Pancytopenia, StatPearls, NCBI Bookshelf](https://ncbi.nlm.nih.gov/books/NBK563146/)
7. [Bone marrow failure syndromes across the age spectrum: diagnostic and therapeutic principles, PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC13499452/)
8. [Comparison of Causes of Pancytopenia Sited in Different Studies Across the World, International Journal of Medical Science in Clinical Research and Review](https://ijmscrr.in/index.php/ijmscrr/article/download/656/453/2214)
9. [A Comprehensive Analysis of Clinical Presentations, Laboratory Findings, and Etiologies of Pancytopenia: A Tertiary Care Experience, PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC11554238/)
10. [New onset pancytopenia in adults: a review of underlying pathologies and their associated clinical and laboratory findings, Leukemia & Lymphoma](https://www.tandfonline.com/doi/full/10.3109/10428194.2013.821703)
11. [Chew S, Kamangar M (2024). Approach to pancytopenia: From blood tests to the bedside. Clinical Medicine 24(5):100235.](https://pubmed.ncbi.nlm.nih.gov/39159748/)
12. [Etiological Spectrum of Pancytopenia Based on Bone Marrow Examination](https://doi.org/10.5005/jablm-11031-0007)
13. [Nakao S (2024). Diagnosis of immune pathophysiology in patients with bone marrow failure. Int J Hematol 119(3):231-239.](https://pubmed.ncbi.nlm.nih.gov/36609840/)
14. [King's College Hospital aplastic anaemia guidance, British Society for Haematology](https://b-s-h.org.uk/media/18192/010420-versionkings-aa-guidance-covid19.pdf)
15. [Aplastic Anemia, NHLBI Hematology Branch, PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6467577)
16. [Blood at 70: its roots in the history of hematology and its birth, PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC4671105/)
17. [Introduction to the Review Series on Bone Marrow Failure, Blood](https://ashpublications.org/blood/article/124/18/2755/33349/Introduction-to-the-Review-Series-on-Bone-Marrow)

---
*Topic: Encyclopedia › Life and health › Human health and medicine › Diseases and injuries › Cardiovascular and blood conditions › Blood disorders (hematologic conditions) › Anemias*

*Initially written Sep 17, 2026 · Reviewed: Oct 21, 2026 · Edited: Oct 15, 2026; Oct 21, 2026 · Last review: Oct 21, 2026*

*Copyright 2026 EdgeChat AI, a subsidiary of Biostate AI.*

License: Edgepedia Community License 1.0, https://www.edgepedia.org/edgepedia/license